dc.contributor.author | Aksu, S. | |
dc.contributor.author | Aktimur, S. H. | |
dc.contributor.author | Arica, D. C. | |
dc.contributor.author | Atay, H. | |
dc.contributor.author | Bektas, O. | |
dc.contributor.author | Buyukasik, Y. | |
dc.contributor.author | Haznedaroglu, I. C. | |
dc.date.accessioned | 2020-06-21T13:46:16Z | |
dc.date.available | 2020-06-21T13:46:16Z | |
dc.date.issued | 2015 | |
dc.identifier.issn | 0390-6078 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12712/14272 | |
dc.description | 20th Congress of European-Hematology-Association -- JUN 11-14, 2015 -- Vienna, AUSTRIA | en_US |
dc.description | aktimur, sude hatun/0000-0002-7468-1721; Bayram, Cem/0000-0001-8717-4668; Haznedaroglu, Ibrahim C./0000-0001-8028-9462; Karakus, sema/0000-0001-7615-4581; Malkan, Umit Yavuz/0000-0001-5444-4895; Koca, Ebru/0000-0002-7566-4456 | en_US |
dc.description | WOS: 000361204904284 | en_US |
dc.description.abstract | … | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Ferrata Storti Foundation | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.title | Generic Imatinib Mesylate Is As Effective As Original Glivec in the Management of Cml | en_US |
dc.type | conferenceObject | en_US |
dc.contributor.department | OMÜ | en_US |
dc.identifier.volume | 100 | en_US |
dc.identifier.startpage | 690 | en_US |
dc.identifier.endpage | 690 | en_US |
dc.relation.journal | Haematologica | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |